Roivant sciences ltd.ROIV.US Overview

US StockHealthcare

(No presentation for ROIV)

Overview AI Analysis Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ROIV Overall Performance

ROIV AI Analysis & Strategy

ROIV Recent Performance

2.89%

Roivant sciences ltd.

2.27%

Avg of Sector

0.07%

S&P500

ROIV PowerScanner

ROIV Key Information

ROIV Valuation Metrics

ROIV Earnings Table

ROIV Profile

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.